<code id='C94F557753'></code><style id='C94F557753'></style>
    • <acronym id='C94F557753'></acronym>
      <center id='C94F557753'><center id='C94F557753'><tfoot id='C94F557753'></tfoot></center><abbr id='C94F557753'><dir id='C94F557753'><tfoot id='C94F557753'></tfoot><noframes id='C94F557753'>

    • <optgroup id='C94F557753'><strike id='C94F557753'><sup id='C94F557753'></sup></strike><code id='C94F557753'></code></optgroup>
        1. <b id='C94F557753'><label id='C94F557753'><select id='C94F557753'><dt id='C94F557753'><span id='C94F557753'></span></dt></select></label></b><u id='C94F557753'></u>
          <i id='C94F557753'><strike id='C94F557753'><tt id='C94F557753'><pre id='C94F557753'></pre></tt></strike></i>

          leisure time

          leisure time

          author:knowledge    Page View:4381
          Illustration of a road with a chasm in the middle, indicating the end of a deal or a problem with a deal
          Adobe

          A deal is never really done until it’s done.

          On Tuesday, two different proposed insurance plan acquisitions on different sides of the country called it quits — one of them for the second time.

          advertisement

          California-based Medicare Advantage insurer SCAN Group has been trying to buy CareOregon, an insurer offering coverage to half a million people in Oregon’s state health plan, since January 2023. National insurer Elevance has also been trying to buy Blue Cross and Blue Shield of Louisiana since last January. The on-again, off-again purchase was paused in September 2023 because of state regulators’ concerns, but was resubmitted with a slightly different plan in December.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more
          United colonoscopy coverage change 'may cost lives,' doctors say
          United colonoscopy coverage change 'may cost lives,' doctors say

          AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

          ChristineKao/STATTheFoodandDrugAdministration’sapprovalonFridayoftwogenetherapiesforsicklecelldiseas